CHL1, ITGB3, and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study - Probst-Schendzielorz, K; Scholl, C; Efimkina, O (Pharmacogenomics, 2015)
et al.